Effects of Fractionated Proton Irradiation in Combination with 1-β-D-Arabinofuranosylcytosine on B16 Murine Melanoma In Vivo

Abstract: This study is a search for means of sensitization of malignant tumors to proton radiation among DNA damage repair inhibitors. It has been found that in the presence of 1-β-D-arabinofuranosylcytosine (AraC), five weekly proton irradiations at a total focal dose of 50 Gy lead to a more pronounced inhibition of B16 murine melanoma growth than the same irradiation without AraC (p < 0.05). This effect, associated with a decrease in the proliferative activity of cells in the general population and a decrease in the number of cancer stem cells specifically in the AraC+Protons group, is promising for further improvement of proton radiotherapy. © Pleiades Publishing, Ltd. 2024. ISSN 1547-4771, Physics of Particles and Nuclei Letters, 2024, Vol. 21, No. 6, pp. 1208–1218. Pleiades Publishing, Ltd., 2024.

Авторы
Zamulaeva I.A. , Matchuk O.N. , Selivanova E.I. , Mosina V.A. , Abramova M.R. , Saburov V.O. , Koryakin S.N. , Ivanov S.A. , Kaprin A.D. , Boreyko A.V. , Chausov V.N. , Krasavin E.A.
Номер выпуска
6
Язык
Английский
Страницы
1208-1218
Статус
Опубликовано
Том
21
Год
2024
Организации
  • 1 A. Tsyb Medical Radiological Research Centre, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Obninsk, Russian Federation
  • 2 Joint Institute for Nuclear Research, Dubna, Russian Federation
  • 3 RUDN University, Moscow, Russian Federation
  • 4 National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Obninsk, Russian Federation
  • 5 P. Hertsen Moscow Oncology Research Institute, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Ключевые слова
1-β-D-arabinofuranosylcytosine (AraC); cancer stem cells; melanoma; proton radiation; radiosensitizer
Цитировать
Поделиться

Другие записи